ERICH3: vesicular association and antidepressant treatment response

Selective serotonin reuptake inhibitors (SSRIs) are standard of care for major depressive disorder (MDD) pharmacotherapy, but only approximately half of these patients remit on SSRI therapy. Our previous genome-wide association study identified a single-nucleotide polymorphism (SNP) signal across th...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Molecular psychiatry Ročník 26; číslo 6; s. 2415 - 2428
Hlavní autori:	Liu, Duan, Zhuang, Yongxian, Zhang, Lingxin, Gao, Huanyao, Neavin, Drew, Carrillo-Roa, Tania, Wang, Yani, Yu, Jia, Qin, Sisi, Kim, Daniel C, Liu, Erica, Nguyen, Thanh Thanh Le, Biernacka, Joanna M, Kaddurah-Daouk, Rima, Dunlop, Boadie W, Craighead, W Edward, Mayberg, Helen S, Binder, Elisabeth B, Frye, Mark A, Wang, Liewei, Weinshilboum, Richard M
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Nature Publishing Group 01.06.2021
Predmet:	Antidepressants Antidepressive Agents - therapeutic use Cell culture Central nervous system Clathrin Clinical trials Culture media Depressive Disorder, Major - drug therapy Depressive Disorder, Major - genetics Drug therapy Gene polymorphism Genome-wide association studies Genome-Wide Association Study Genomes Humans Immunofluorescence Isoforms Lysates Mental depression Patients Serotonin - therapeutic use Serotonin uptake inhibitors Serotonin Uptake Inhibitors - therapeutic use Single-nucleotide polymorphism Systematic review
ISSN:	1359-4184, 1476-5578, 1476-5578
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!